ArticleJournal of human immunity2026

Expanding the scope of PI3K-δ inhibition: Leniolisib treatment in PRKCD deficiency.

Lorenzo Lodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.